Endotoxin Release Due to Ciprofloxacin Measured by Three Different Methods

REFERENCES

• Cross AS, Opal SM. Endotoxin's role in gram-negative bacterial infection. Curr Opin Infect Dis 1995; 8: 156–163.
   Web of Science ®Google Scholar
• Reilly J, Compagnon A, Tuornier P, Bastin R, DuSuit H. Les accidents du traitment des fièvres typhoides par la chloromycetine. Ann Med (Paris) 1950; 51: 597–629.
   PubMedGoogle Scholar
• Spink WW, Hall WH, Shaffer JM, Braude Al. Human brucellosis: its specific treatment with a combination of strep-tomycin and sulfadiazine. JAMA 1948; 136: 382–387.
   PubMed Web of Science ®Google Scholar
• Shenep JL, Flynn PM, Barrett FF, Stidham GL, Westenkirchner DF. Serial quantitation of endotoxemia and bacteremia during therapy for Gram-negative bacterial sepsis - concise communications. J Infect Dis 1988; 157: 565–568.
   PubMed Web of Science ®Google Scholar
• Shenep JL, Barton RP, Morgan KA. Role of antibiotic class in the rate of liberation of endotoxin during therapy for experimental Gram-negative bacterial sepsis. J Infect Dis 1985; 151: 1012–1018.
   PubMed Web of Science ®Google Scholar
• Jackson JJ, Kropp H. Differences in mode of action of β-lactam antibiotics influence morphology, LPS release and in vivo antibiotic efficacy. J Endotoxin Res 1996; 3: 201–218.
   Google Scholar
• Bucklin SE, Fujihara Y, Leeson MC, Morrison DC. Differential antibiotic-induced release of endotoxin from Gram-negative bacteria. Eur J Clin Microbiol Infect Dis 1994; 13, Suppl 1: 43–51.
   PubMedGoogle Scholar
• Jackson JJ, Kropp H. β-lactam antibiotic-induced release of free endotoxin: in vitro comparison of penicillin-binding (PBP) 2-specific imipenem and PBP 3-specific cef-tazidime. J Infect Dis 1992; 165: 1033–1041.
   PubMed Web of Science ®Google Scholar
• Periti P, Mazzei T. Antibiotic-induced release of bacterial cell wall components in the pathogenesis of sepsis and septic shock: a review. J Chemother 1998; 10: 427–448.
   PubMed Web of Science ®Google Scholar
• Prins JM, van Agtmael MA, Kuijper EJ, van Deventer SJH, Speelman P. Antibiotic-induced endotoxin release in patients with gram-negative urosepsis: a double-blind study comparing imipenem and ceftazidime. J Infect Dis 1995; 172: 886–891.
   PubMed Web of Science ®Google Scholar
• McConnell JS, Cohen J: Release of endotoxin from Escherichia coli by quinolones. J Antimicrob Chemother 1986; 18: 765–766.
   PubMed Web of Science ®Google Scholar
• Van den Berg C, de Neeling AJ, Schot CS, Hustinx WN, Wemer J, de Wildt DJ. Delayed antibiotic-induced lysis of Escherichia coli in vitro is correlated with enhancement of LPS release. Scand J Infect Dis 1992; 24: 619–27.
   PubMed Web of Science ®Google Scholar
• Evens ME, Pollack M. Effect of antibiotic class and con-centration on the release of lipopolysaccharide from Escherichia coli. J Infect Dis 1993; 167: 1336–43.
   PubMed Web of Science ®Google Scholar
• Eng RH, Smith SM, Fan-Havard P, Ogbara T. Effect of antibiotics on endotoxin release from gram-negative bacteria. Diagn Microbiol Infect Dis 1993; 16: 185–9.
   PubMed Web of Science ®Google Scholar
• Crosby HA, Sion JF, Penn CW, Elliott TS. Antibiotic-induced release of endotoxin from bacteria in vivo. J Med Microbiol 1994; 40: 23–30.
   PubMed Web of Science ®Google Scholar
• Prins JM, Kuijper EJ, Mevissen MLCM, Speelman P, van Deventer SJH. Release of tumor necrosis factor alpha and interleukin 6 during antibiotic killing of Escherichia coli in whole blood: influence of antibiotic class, antibiotic concentra-tion, and presence of septic serum. Infect Immun 1995; 63: 2236-2242.
   Google Scholar
• Frieling JTM, Mulder JA, Hendriks T, Curfs JHAJ, Van der Linden CJ, Sauerwein RW. Differential induction of pro-and antiinflammatory cytokines in whole blood by bacteria: effects of antibiotic treatment. Antimicrob Agents Chemother 1997; 41: 1439–1443.
   PubMed Web of Science ®Google Scholar
• Trautmann M, Zick R, Rukavina T, Cross AS, Marre R. Antibiotic-induced release of endotoxin: In vitro comparison of meropenem and other antibiotics. J Antimicrob Chemother 1998; 41: 163–169.
   PubMed Web of Science ®Google Scholar
• National Committee for Clinical Laboratory Standards: Methods for dilution antimicrobial susceptibility testing for bac-teria that grow aerobically. Approved standard M7-A3. NCCLS, Villanova, PA, USA, 1993.
   Google Scholar
• Berger D, Marzing E, Marzing M, Seger HG. Quantitative endotoxin determination in blood - chromogenic modification of the Limulus amebocyte lysate test. Eur J Surg Res 1988; 20: 128–136.
   PubMed Web of Science ®Google Scholar
• Kaufman BM, Cross AS, Futrovsky SL, Sidberry HF, Sadoff JC. Monoclonal antibodies reactive with K1-encapsulat-ed Escherichia coli lipopolysaccharide are opsonic and pro-tect mice against lethal challenge. Infect Immun 1986; 52: 617–619.
   PubMed Web of Science ®Google Scholar
• Westphal O, Jann K. Bacterial lipopolysaccharides: extraction with phenol-water and further applications of the procedure; in Whistler RL (ed): Methods in Carbohydrate Chemistry, vol. 5. New York: Academic Press, 1965: 83-91.
   Google Scholar
• Ziegler-Heitbrock HWL, Thiel E, Ftitterer A, Herzog V, Wirtz A, Riethmtiller G. Establishment of a human cell line (Mono Mac 6) with characteristics of mature monocytes. Int J Cancer 1988; 41: 456–461.
   PubMed Web of Science ®Google Scholar
• Sachs L. Angewandte Statistik. Springer, Berlin-Heidelberg-New York, 1978: 315-319.
   Google Scholar
• Waage A, Brandtzaeg P, Espevick T. Current under-standing of the pathogenesis of Gram-negative shock. Infect Dis Clin North Am 1991; 5: 781–791.
   PubMedGoogle Scholar
• Beutler B, Milsark IW, Cerami AC. Passive immuniza-tion against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science 1985; 229: 868–72.
   Web of Science ®Google Scholar
• Kirikae T, Kirikae F, Saito S, Tominaga K, Tamura H, Uemura Y, Yokochi T, Nakano M: Biological characterization of endotoxins released from antibiotic-treated Pseudomonas aeruginosa and Escherichia coli. Antimicrob Agents Chemother 1998; 42: 1015–1021.
   PubMed Web of Science ®Google Scholar
• Ball P, Tillotson G: Tolerability of fluoroquinolone antibiotics. Past, present and future. Drug Safety 1996; 13: 343–358.
   Google Scholar
• Trautmann M, Held TK, Susa M, Karajan MA, Wulf A, Cross AS, Marre R. Bacterial lipopolysaccharide (LPS)-specific antibodies in commercial human immunoglobulin prepara-tions: superior antibody content of an IgM-enriched product. Clin Exp Immunol 1998; 111: 81–90.
   PubMed Web of Science ®Google Scholar
• Flegel WA, Baumstark MW, Weinstock C, Berg A, Northoff H. Prevention of endotoxin-induced monokine release by human low- and high-density lipoproteins and by apolipoprotein A-I. Infect Immun 1993; 61: 5140–5146.
   PubMed Web of Science ®Google Scholar
• Leeson MC, Morrison DC. Induction of proinflammato-ry responses in human monocytes by particulate and soluble form of lipopolysaccharide. Shock 1994; 2: 235–245.
   PubMed Web of Science ®Google Scholar
• Bhattacharjee AK, Opal SM, Taylor R, et al. A nonco-valent complex vaccine prepared with detoxified Escherichia coli J5 (Rc chemotype) lipopolysaccharide and Neisseria men ingitidis group B outer membrane protein produces pro-tective antibodies against gram-negative bacteremia. J Infect Dis 1996; 173: 1157–1163.
   PubMed Web of Science ®Google Scholar
• Morrison DC. Antibiotic-mediated release of endotoxin and the pathogenesis of gram-negative sepsis. Prog Clin Biol Res 1998; 397: 199–207.
   PubMedGoogle Scholar
• Holzheimer RG. The significance of endotoxin release in experimental and clinical sepsis in surgical patients - evi-dence for antibiotic-induced endotoxin release? Infection 1998; 26: 77–84.
   PubMed Web of Science ®Google Scholar